Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer’s disease triple transgenic mice
Julia Hernandez-Rapp, Sara Rainone, Claudia Goupil, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 116

Showing 26-50 of 116 citing articles:

miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s disease
Sang‐Won Han, Jung‐Min Pyun, Paula J. Bice, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Role of exercise on ncRNAs and exosomal ncRNAs in preventing neurodegenerative diseases: a narrative review
Shangwu Liu, Runhong Zhang, Jamal Hallajzadeh
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Posterior cingulate cortex microRNA dysregulation differentiates cognitive resilience, mild cognitive impairment, and Alzheimer's disease
Scott Counts, John S. Beck, Bryan Maloney, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 2
Open Access | Times Cited: 1
Electrochemiluminescence resonance energy transfer system between GNRs and Ru(bpy)32+: Application in magnetic aptasensor for β-amyloid
Hong Ke, Haifeng Sha, Lanying Li, et al.
Biosensors and Bioelectronics (2017) Vol. 100, pp. 266-273
Closed Access | Times Cited: 81
Co-occurrence of mixed proteinopathies in late-stage Huntington’s disease
Isabelle St‐Amour, Andréanne Turgeon, Claudia Goupil, et al.
Acta Neuropathologica (2017) Vol. 135, Iss. 2, pp. 249-265
Closed Access | Times Cited: 79
Nose-to-brain delivery of enveloped RNA - cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases
Eleni Samaridou, Hannah Walgrave, Evgenia Salta, et al.
Biomaterials (2019) Vol. 230, pp. 119657-119657
Open Access | Times Cited: 72
MiR-21 attenuates apoptosis-triggered by amyloid-β via modulating PDCD4/ PI3K/AKT/GSK-3β pathway in SH-SY5Y cells
Mei-Guo Feng, Cuifang Liu, Li Chen, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 101, pp. 1003-1007
Closed Access | Times Cited: 69
Procyanidins and Alzheimer’s Disease
Siqi Zhao, Li Zhang, Chenlu Yang, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 8, pp. 5556-5567
Closed Access | Times Cited: 61
The Role of Non-coding RNAs in Alzheimer’s Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers
Yuan Zhang, Yanfang Zhao, Xiang Ao, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 51
Alzheimer’s Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target
Meng Zhang, Zhigang Bian
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 42
Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer’s disease by meta-analysis and adaptive boosting ensemble learning
Sze Chung Yuen, Xiaonan Liang, Hongmei Zhu, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 42
Exosomal miR-132-3p from mesenchymal stromal cells improves synaptic dysfunction and cognitive decline in vascular dementia
Xiaotang Ma, Yan Wang, Yumeng Shi, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30
MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
Ivana Raffaele, Serena Silvestro, Emanuela Mazzon
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4736-4736
Open Access | Times Cited: 21
MicroRNA-132 attenuates neurobehavioral and neuropathological changes associated with intracerebral hemorrhage in mice
Yaowen Zhang, Bin Han, Yating He, et al.
Neurochemistry International (2016) Vol. 107, pp. 182-190
Closed Access | Times Cited: 60
Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer’s disease pathogenesis: Potential strategies to protect the LC against aging
Akiko Satoh, Koichi Iijima
Brain Research (2017) Vol. 1702, pp. 17-28
Closed Access | Times Cited: 60
Targeted Gene Editing of Glia Maturation Factor in Microglia: a Novel Alzheimer’s Disease Therapeutic Target
Sudhanshu P. Raikwar, Ramasamy Thangavel, Iuliia Dubova, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 1, pp. 378-393
Open Access | Times Cited: 59
MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer
Manxin Xie, Ziyi Fu, Jianxiang Cao, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 102, pp. 286-294
Closed Access | Times Cited: 58
Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease
Alex Cleber Improta‐Caria, Carolina Kymie Vasques Nonaka, Bruno Raphael Ribeiro Cavalcante, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4977-4977
Open Access | Times Cited: 49
Environmental enrichment prevents Aβ oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways
Zhiyun Wei, Xingjun Meng, Rachid El Fatimy, et al.
Neurobiology of Disease (2019) Vol. 134, pp. 104617-104617
Open Access | Times Cited: 44
Integrated miRNA-Seq and mRNA-Seq Study to Identify miRNAs Associated With Alzheimer’s Disease Using Post-mortem Brain Tissue Samples
Qingqin S. Li, Diana Cai
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 37
Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer’s Disease
Devyani Bhatnagar, Shreya Ladhe, Dileep Kumar
Molecular Neurobiology (2023) Vol. 60, Iss. 10, pp. 5954-5974
Closed Access | Times Cited: 16
Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies
Ajmal Nassar, Sairaj Satarker, Prasada Chowdari Gurram, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 10, pp. 5557-5577
Open Access | Times Cited: 14
miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q
Nan‐Jie Xu, Ang-Di Li, Li-Li Ji, et al.
European Journal of Histochemistry (2019) Vol. 63, Iss. 2
Open Access | Times Cited: 37
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease
Chiara Burgaletto, Chiara Bianca Maria Platania, Giulia Di Benedetto, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 31
Brain microRNAs are associated with variation in cognitive trajectory in advanced age
Aliza P. Wingo, Mengli Wang, Jiaqi Liu, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20

Scroll to top